1. Home
  2. USEG vs XLO Comparison

USEG vs XLO Comparison

Compare USEG & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Energy Corp. (DE)

USEG

U.S. Energy Corp. (DE)

HOLD

Current Price

$0.81

Market Cap

46.5M

Sector

Energy

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

SELL

Current Price

$8.40

Market Cap

39.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
USEG
XLO
Founded
1966
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.5M
39.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
USEG
XLO
Price
$0.81
$8.40
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$3.50
$28.00
AVG Volume (30 Days)
3.0M
33.8K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
55.21
N/A
EPS
N/A
N/A
Revenue
$32,379,000.00
$43,766,000.00
Revenue This Year
$114,854.51
N/A
Revenue Next Year
N/A
$168.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$0.66
$0.46
52 Week High
$2.75
$9.25

Technical Indicators

Market Signals
Indicator
USEG
XLO
Relative Strength Index (RSI) 45.31 71.93
Support Level $0.66 $0.62
Resistance Level $1.08 $9.22
Average True Range (ATR) 0.07 0.44
MACD 0.00 -0.29
Stochastic Oscillator 47.19 26.43

Price Performance

Historical Comparison
USEG
XLO

About USEG U.S. Energy Corp. (DE)

US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: